Cargando…

Psoriatic Arthritis and Metabolic Syndrome: Is There a Role for Disease Modifying Anti-Rheumatic Drugs?

Although psoriatic arthritis (PsA) primarily leads to joint and skin damage, it is associated with higher prevalence of metabolic syndrome (MetS) and its components, namely hypertension, dyslipidemia, obesity, and type II diabetes. Additionally, chronic inflammation is known to aggravate these cardi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Atzeni, Fabiola, Gerratana, Elisabetta, Francesco Masala, Ignazio, Bongiovanni, Sara, Sarzi-Puttini, Piercarlo, Rodríguez-Carrio, Javier
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8435605/ https://www.ncbi.nlm.nih.gov/pubmed/34527685 http://dx.doi.org/10.3389/fmed.2021.735150

Ejemplares similares

A Review of Chronic Musculoskeletal Pain: Central and Peripheral Effects of Diclofenac
por: Atzeni, Fabiola, et al.
Publicado: (2018)

Cardiovascular Imaging Techniques in Systemic Rheumatic Diseases
por: Atzeni, Fabiola, et al.
Publicado: (2018)

Frequency of Renal Function Parameter Abnormalities in Patients with Psoriatic Arthritis and Rheumatoid Arthritis: Real-World Evidence from Clinical Practice
por: Atzeni, Fabiola, et al.
Publicado: (2022)

Comparison of Efficacy of Ketoprofen and Ibuprofen in Treating Pain in Patients with Rheumatoid Arthritis: A Systematic Review and Meta-Analysis
por: Atzeni, Fabiola, et al.
Publicado: (2021)

Cost Effectiveness Analysis of Disease-Modifying Antirheumatic Drugs in Rheumatoid Arthritis. A Systematic Review Literature
por: Benucci, Maurizio, et al.
Publicado: (2011)

Noninvasive imaging methods for evaluating cardiovascular involvement in patients with rheumatoid arthritis before and after anti-TNF drug treatment
por: Atzeni, Fabiola, et al.
Publicado: (2019)

Factors correlated with improvement of endothelial dysfunction during rituximab therapy in patients with rheumatoid arthritis
por: Benucci, Maurizio, et al.
Publicado: (2013)

Cannabis and Autoimmunity: Possible Mechanisms of Action
por: Giorgi, Valeria, et al.
Publicado: (2021)

Reactivation of occult hepatitis B virus infection under treatment with abatacept: a case report
por: Talotta, Rossella, et al.
Publicado: (2016)

Microbial Agents as Putative Inducers of B Cell Lymphoma in Sjögren's Syndrome through an Impaired Epigenetic Control: The State-of-The-Art
por: Talotta, Rossella, et al.
Publicado: (2019)

Correlation of the score for subjective pain with physical disability, clinical and radiographic scores in recent onset rheumatoid arthritis
por: Sarzi-Puttini, Piercarlo, et al.
Publicado: (2002)

Effect of adalimumab on neutrophil function in patients with rheumatoid arthritis
por: Capsoni, Franco, et al.
Publicado: (2005)

Accelerated subcutaneous nodulosis in patients with rheumatoid arthritis treated with tocilizumab: a case series
por: Talotta, Rossella, et al.
Publicado: (2018)

Rheumatoid Arthritis disease activity assessment in routine care: performance of the most widely used composite disease activity indices and patient-reported outcome measures
por: Salaffi, Fausto, et al.
Publicado: (2021)

Serological epitope profile of anti-Ro52–positive patients with systemic autoimmune rheumatic diseases
por: Infantino, Maria, et al.
Publicado: (2015)

Effects of Anti-TNF Alpha Drugs on Disability in Patients with Rheumatoid Arthritis: Long-Term Real-Life Data from the Lorhen Registry
por: Filippini, Matteo, et al.
Publicado: (2014)

The Co-Morbidity between Bipolar and Panic Disorder in Fibromyalgia Syndrome
por: Alciati, Alessandra, et al.
Publicado: (2020)

The Immunogenicity of Branded and Biosimilar Infliximab in Rheumatoid Arthritis According to Th9-Related Responses
por: Talotta, Rossella, et al.
Publicado: (2017)

Determinants of Risk Infection During Therapy with Anti TNF-Alpha Blocking Agents in Rheumatoid Arthritis
por: Benucci, M, et al.
Publicado: (2012)

Anti-cyclic citrullinated peptide antibodies in primary Sjögren syndrome may be associated with non-erosive synovitis
por: Atzeni, Fabiola, et al.
Publicado: (2008)

How to handle patients with autoimmune rheumatic and inflammatory bowel diseases in the COVID-19 era: An expert opinion
por: Sarzi-Puttini, Piercarlo, et al.
Publicado: (2020)

Doctors' Insights into the Patient Perspective: A Qualitative Study in the Field of Chronic Pain
por: Zanini, Claudia, et al.
Publicado: (2014)

Building bridges between doctors and patients: the design and pilot evaluation of a training session in argumentation for chronic pain experts
por: Zanini, Claudia, et al.
Publicado: (2015)

No Correlations Between the Development of Specific IgA and IgM Antibodies Against Anti-TNF Blocking Agents, Disease Activity and Adverse Side Reactions in Patients with Rheumatoid Arthritis
por: Benucci, Maurizio, et al.
Publicado: (2013)

The Rheumatology Drugs for COVID-19 Management: Which and When?
por: Atzeni, Fabiola, et al.
Publicado: (2021)

Development and validation of the self-administered Fibromyalgia Assessment Status: a disease-specific composite measure for evaluating treatment effect
por: Salaffi, Fausto, et al.
Publicado: (2009)

Central motor control failure in fibromyalgia: a surface electromyography study
por: Casale, Roberto, et al.
Publicado: (2009)

The Microbiome in Connective Tissue Diseases and Vasculitides: An Updated Narrative Review
por: Talotta, Rossella, et al.
Publicado: (2017)

Is atherosclerosis an autoimmune disease?
por: Matsuura, Eiji, et al.
Publicado: (2014)

Metabolic Syndrome and Its Components Have a Different Presentation and Impact as Cardiovascular Risk Factors in Psoriatic and Rheumatoid Arthritis
por: Atzeni, Fabiola, et al.
Publicado: (2023)

Adalimumab clinical efficacy is associated with rheumatoid factor and anti-cyclic citrullinated peptide antibody titer reduction: a one-year prospective study
por: Atzeni, Fabiola, et al.
Publicado: (2006)

Costs associated with rheumatoid arthritis in Italy: past, present, and future
por: Benucci, Maurizio, et al.
Publicado: (2016)

Efficacy and Treatment Costs of Monotherapy with bDMARDs in the Treatment of Rheumatoid Arthritis in Patients Intolerant to or Inappropriate to Continue Treatment with Methotrexate
por: Batticciotto, Alberto, et al.
Publicado: (2016)

Effect of disease-modifying anti-rheumatic drugs on bone structure and strength in psoriatic arthritis patients
por: Simon, David, et al.
Publicado: (2019)

Biology and therapy of fibromyalgia. Genetic aspects of fibromyalgia syndrome
por: Buskila, Dan, et al.
Publicado: (2006)

What is the role of rheumatologists in the era of COVID-19?
por: Marotto, Daniela, et al.
Publicado: (2020)

Predicting Severe/Critical Outcomes in Patients With SARS-CoV2 Pneumonia: Development of the prediCtion seveRe/crItical ouTcome in COVID-19 (CRITIC) Model
por: Salaffi, Fausto, et al.
Publicado: (2021)

Identifying the symptom and functional domains in patients with fibromyalgia: results of a cross-sectional Internet-based survey in Italy
por: Salaffi, Fausto, et al.
Publicado: (2016)

Clinical Comparison of QUANTA Flash dsDNA Chemiluminescent Immunoassay with Four Current Assays for the Detection of Anti-dsDNA Autoantibodies
por: Infantino, Maria, et al.
Publicado: (2015)

Patients’, physicians’, nurses’, and pharmacists’ preferences on the characteristics of biologic agents used in the treatment of rheumatic diseases
por: Scalone, Luciana, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_0d88js4ejg0g8m8m9053cion5t